Medpharma Valeant Pharmaceuticals
- Achieve $5M of generics portfolio through integrated strategic & tactical plans, indirect management of sales force & trade marketing teams and ongoing Sales/MS tracking
- Launch of TheraPearl® (www.Therapearl.com) in UAE to generate AED 1M, crafted full commercial plan with 3 years P&L for the region, from-scratch HCP & Consumer campaigns and over 900 POSM in big retailers such as Boots®
- Re-branding of La Femme® -feminine hygiene category- in cooperation with R&D, QA and RA teams. Revamped outer & inner pack artwork, actual product plus 2 separate campaigns to HCP & DTC.
- 2017 La Femme® launch in Egypt expanding feminine hygiene market.
- Assigned in collaboration with Valeant BDM to exclusively commercialize Actipatch® (www.actipatch.com) in MENA region in 2017
- A&P budget & OPEX control for OTC & generics portfolio
- Market research & consumer insights analysis to prepare investment plans with ROI
- Medical & product training workshops to equip sales team with needed knlowledge in selling thier products & attain thier budgets
- Ongoing coaching and product detailing monitoring of sales team on medpharma & agents headcounts
- Life cycle management of Medpharma mature OTC/Generics portfolio (AED 9M) which includes Dandruff shampoo, baby cream, Antibiotic, and cough syrups.